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Although several abnormalities of lipid metabolism 
have been associated with abnormal cornification in 
humans, evidence that these lipids directly provoke ab-
normal scale is lacking. One recently described example 
of a lipid abnormality in ichthyosis is absence of 
the enzyme steroid sulfatase in recessive X-linked ich-
thyosis (RXLI). This enzyme normally desulfates choles-
terol sulfate (CS) and sulfated steroid hormones, includ-
ing dehydroepiandrosterone sulfate (DHEAS). As a re-
sult of this enzyme deficiency, patients with RXLI ac-
cumulate CS in their blood and skin. To detemine 
whether sulfated sterols are the specific cause of in-
creased scale, we applied CS, DHEAS, cholesterol, or 
vehicle alone to the backs of hairless mice. In animals 
treated with CS, but not with DHEAS or with vehicle, 
visible scale without erythema appeared after 1 week, 
peaked at 2 weeks, and then diminished. When the dose 
of CS was doubled, abnormal scale reappeared and then 
decreased again. CS-induced scale was reversible, clear-
ing within 3 days of discontinuation of treatment. Be-
cause there was no acanthosis, dermal inflammation, 
abnormal transepidermal water loss, or increased label-
ing index, it appears that the 3-fold increase in thickness 
of the stratum corneum in CS-treated animals is due to 
a direct effect on this layer. 
Durin g the past several years, it has become more apparen t 
that lipids are involved in corneum cohesion and desquama-
t ion (reviewed in [1- 3]). The lines of ev idence t hat favor this 
association include: (1) appreciation t hat t he lipids in mam-
ma lia n stratum corneum are segregated predominantly within 
intercellular domains [4- 6]; (2) administration of several hy-
pocholesterolemic drugs to humans and to experimental ani-
mals produces ichthyos is [7- 10]; (3) abnormal scaling occu rs 
in acquired clinical disorders of lipid metabolism, such as 
esse ntial fatty acid (EFA) deficiency [11- 13] ; and, (4) patients 
with seve ra l inherited d isorders of lipid metabolism (reviewed 
in 1 4]), such as Refsum's d isease [15], neutral lipid storage 
disease [14,16], multiple sulfatase deficiency [17], and recessive 
X- linked ichthyos is (RXLI) have clinically apparent ichthyosis 
[18]. 
The link between a systemic lipid abnormali ty and pathologic 
sca le has been demonstrated most convincingly in RXLI , where 
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Abbreviations: 
ANS: 8-anilino-1-naphthalene-sulfonic acid 
CS: choleRterol sulfate 
DHEAS: dehydroepiandrosterone sulfate 
DMSO: dimethyl sulfoxide 
EFA: essential fatty ac id 
RXLl: recessive X-linked ichthyosis 
TEWL: transepidermal water loss 
epidermis lacks the enzyme, steroid sulfatase [19,20], a nd one 
of its substrates, cholesterol sulfate, accumulates in t he stratum 
corneum [21 ]. Cholesterol sulfate appears to be generated in 
t he epidermis itself, a nd like other lipids is located at the 
periphery of stratum corneum cells [22,23 ]. 
In order to establish more directly t hat the lipid abnormality 
in RXLI is the cause of t he stratum corneum t hickn ess and 
not simply an epiphenomenon, we have applied cholesterol 
sulfate directly to t he skin of hairless mice. In this mouse 
model, just as in t he "experiment of nature," RXLI, t hickening 
occurs without acanthosis, increased labeling index, dermal 
inflammation , or altered barrier function [24]. 
MATERIALS AND METHODS 
Animals and 'l'opical Applications 
Solutions of cholesterol sulfate (CS, sodium salt, Research Plus 
Bayonne, New Jersey) and dehydroepiandrosterone sulfate (DHEAS, 
sodium salt, Sigma) were prepared by dissolving 0.5- 5 mg of each lipid/ 
ml of dimethyl sulfoxide (DMSO, Sigma). Since cholesterol was insol-
uble in DMSO, in other experiments t he same concentrations of 
cholesterol and CS were solubilized in DMSO:chloroform (50:50, vols). 
Gentle heating to 40"C and vortexing was used to speed this process. 
CS, DHEAS, cholesterol, CS + cholesterol, DMSO alone, or t he 
DMSO:chloroform vehicle alone was applied once daily (total dose: 
0.01 - 0.04 ml) to the backs of 3- to 4-week-old male hairless mice (Hr/ 
hr) obtained from Jackson Labs, Bar Harbor , Maine. In some experi-
ments an imals were housed individually to prevent them from licking 
li ttermates, and drug was always applied over the scapula where ani-
mals could not lick themselves. The animals (5 an imals in each group, 
4 separate experiments) were inspected daily for evidence of abnormal 
scale, which was quantitated on a 0 (no scale) to 4+ (total area covered 
with !.hick scale) basis. At 0-, 1-, 3-, and 7-week in tervals biopsies were 
obtained for the studies detailed below. 
Histology and Determination of Epidermal Histometric Parameters 
At the end of each treatment period sk in biopsies of t reated and 
control skin sites were snap-frozen in liquid nitrogen and sectioned (6 
I-'m) in a cryostat . The frozen sections we re then stained with either 
hematoxylin and eosin or the f1uorophore , 8-anilino-1-naphthalene-
sulfon ic acid (ANS) , wh ich clearly depicts stratum corneum cell mem-
branes [25 ]. Measurements were made of the t hickness of t he stratum 
corneum and viable epidermis with an eyepiece micrometer mounted 
in a Leitz Ortholux II microscope equipped for epif1uorescence as 
previously described [26] and, in addition, the number of nucleated 'cell 
layers was determined at t he same sites. Thickness and number of cell 
layer determinations were made on 5-7 sepa rate biopsy sites (minimum 
of 7 measurements each) t hat displayed an intact stratum corneum and 
appeared to be sectioned perpendicular to t he surface [25 ]. To avoid 
observed bias, all measurements were performed by an observer who 
was unaware of the nature of the prior treatment to that site and who 
did not know the purpose of t his study. Since none of the steroids or 
sterols produced measurable acanthosis, an additional group of animals 
was treated with absolute hexadecane (0.1/ml/day) , an agent that 
produces reproducible hyperplasia [27]. This group served as positive 
controls. 
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Determination of Labeling Indices 
For determination of labeling indices, sites t reated for 1 week with 
CS or control solutions were injected with 10 1-'Ci l ~'H]thymidine (New 
England Nuclear Corp. , 113 Ci/mmoJ) in tradermaiJy 1 h prior to biopsy. 
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The biopsy samples were then fix ed in 2% glutaraldehyde in 0. 1 M 
cacodylate buffer and embedded in paraffi n. Ten micron-thick sections 
were coated with IIford L-4 emulsion , exposed for 1 week, deve loped, 
and t he number of labeled ce lls/1000 basal cells was dete rmined at 3 
d iffe re nt sites. T he sign ifi cance of the different labeling indices of the 
CS-treated vs control animals was determined by Student's t-test. 
M easurement of Tran.sepidermal Water Los.s (TEWL) 
Water loss was measured by passing a stream of dry ni t rogen through 
a fl ow cell fi tted with a cap (1.0-cm orifice) held firmly against the 
surface of t he skin. The moisture content of the effluent was then 
detected in an electrolytic water analyzer (Manufacturers Engineering 
and Equipment Corporation, Warrington, Pennsylvania). All measure-
men ts we re done under ident ical condi tions of environmental temper-
atu re and humidity in ether-anesthesized animals. 
Stero id S ulfatase Assay 
Snap-frozen stratum corneum sheets, that had been separated from 
the viable epidermis by intradermal injection of staphylococcal epider-
mo lytic toxin [25 ], were homogenized in 14 mM Tris-HCI buffer, pH 
8.0, with 0.5% Miranol H2M (a ge nerous gift of the Miranol Co rp.), 
and ste roid sulfatase activity was measured by desulfation of [3H] 
DHEAS [20]. To reduce substrate co mpetition from previously applied 
CS , t he outer stratum corneum was removed by 3 successive cellophane-
tape strippings prior to harvesting sheets for enzyme assay. As an 
additional control for substrate competition, ste roid sulfatase levels 
were measured immediately after application of the initial 25-pg dose 
of CS. No reduction in [3H]DHEAS desulfation was observed. Finally, 
to e nsure that altered ste roid sulfatase levels did not simply refl ect 
diffe re nces in stratum co rneum th ickness, we compared enzyme activity 
in normal mouse and human stratum co rneum, normal human plantar 
stratum corneum, and stratum corneum from 2 patients with ichthyosis 
vu lgaris. Again , no differences were encountered. Protein content was 
determined on aliquots of stratum co rneum homogenized without Mir-
anol H 2M by the Lowry method [28 ], which gives values similar to 
those obtained by hydrolys is in 6 N HCI and amino acid analysis 
(unpublished da ta). 
Dem o n stra tion of Pen.tration. of Applied Cholesterol Sulfa te 
To assess whether applied CS reaches the depth of the stratum 
corneum, I"H] CS, 107 cpm , prepared by the method of Sobe l et al 
[29), was placed withi n a 0 .. 5-cm2 ring taped to the anima l's back for 
24 h in 2 separate experiments. The ring prevented the animals from 
lick ing themselves, and animals were caged individually to insure that. 
they did not lick each other. At the end of 24 h the area within the ring 
was tape-str ipped successively. When the glistening layer, representing 
the upper surface of the viable epidermis, was reached, the remaining 
fu ll- t hickness skin was removed by a 6- mm punch biopsy extending to 
the s ubcutaneous fat. Each stripping and the viable layer sample was 
then a dded to a sc in tillation vial containing 4 ml of Scint.iverse II 
(Fisher Scientific) and counted in a Beckman liquid scintillation spec-
t rometer. 
RESULTS 
Clinical Observations 
C S, 2.5 mg/ ml , 0.02 ml in eit her t he DMSO or chloro-
form:DMSO vehicle , when app lied daily produced visible sca le 
in less than 14 days (Fig 1). CS-induced sca le cou ld be prevented 
by simulta neous applicat ion of cholesterol in the ch loro-
fo rm:DMSO vehic le. In contrast, neither DHEAS, cholesterol , 
nor the vehicles alone produced any visible scale at this time 
period. By doubling the concentration of CS to 5 mg/ ml (0.02 
ml applied daily), comparable scale appeared by day 7. A 
doubling of dose (to 0.04 ml per day) resulted in more evident 
scale (2+) in less than 1 week. Scale could be made more visible 
by passing ether vapor on a cotton ball over the skin surface 
(Fig 1, cf. CS vs vehicle-treated control) . Neither the amount 
of scale nor t he rate of appearance of scale, was inf1uenced by 
dietary choleste rol con te nt: animals maintained on either a 2% 
cholesterol (high cholesterol) or a cholestero l-free diet behaved 
similarly. 
Regardless of t he applied dose, as CS cont inued to be app lied 
over the following 2 weeks, scale diminished unt il it was barely 
detectible. However, with further doubling of the applied dose 
of CS, scale could be produced again (e.g., 0.02 ml--> 0.04 ml) . 
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FIG L A normal vehicle-treated control mouse (left) is shown next 
to a mouse treated with 0.4 ml CS (5 mg/ ml ) daily for 14 days. Sca le 
was accentuated for photographic purposes by passing ether on a cotton 
swab near the skin surface. 
Histologic and Histometric Observations 
The histology of CS-treated and control epidermis is shown 
in Fig 2. There was no acanthosis, increased mitoses or in -
creased cellu larity in t he dermis. Whereas t he stratum c~rneum 
from animals treated with DHEAS for 2 weeks was somewhat 
thicker than control (but not sufficient ly hyperkeratotic to 
produce visible scale) , the stratum corneum from animals 
treated wit h CS for 2 weeks was a lmost 3 t imes t he thickness 
of the vehicle control (p < 0.001) and twice the thic kness of 
t hat treated with comparable doses of DHEAS (Table I). At 
earlier time points (3- 10 days) the thickness of the stratum 
corneum increased slowly, in parallel wi t h the emergence of 
vis ible scale. In cont rast, the viable epidermis of both CS-
t reated and DHEAS-treated viab le epidermis was not t hicke r 
than the vehicle control (Table I). Whereas hexadecane a lso 
produced visible scale and increased stratum corneum thick -
ness, the viable epidermis was much t hicker (Tab le I), a nd 
t here were mcreased numbers of mi totic figures and increased 
dermal cellulan ty. 
Labeling Indices 
The histologic results, which suggested a n absence of in -
creased e~ide.rmal cell tu rnover, were supported by the labeling 
mdex act1v1tJes. We found no significant differences in t he 
mitotic indices of skin t reated with topical CS vs normal skin 
(p > 0.1) (Table II) , but hexadecane-treated s kin demonstrated 
11 2- to 3-fold increase in mitotic index , a difference t hat was 
statistically significant (Table II, p < 0.01). 
Stratum Corneum M etabolic Studies 
The observation that the scale produced by topical CS even-
tually disappeared d~spite continued applications, suggested 
that CS m1gh t cause mcreased stratum corneum steroid sulfa-
tase activity [22,23]. T o assess this possibility, we measured 
steroid sul fatase activity in stratum corneum sheets obtained 
at regu lar intervals during topical applications. Although en-
zyme activity steadily increased between 0 a nd 3 weeks (Table 
III), no further increase, and perhaps a slight decrease, occurred 
between 3 and 7 weeks (data not shown). Alterations in enzyme 
activity cou ld not be explained by changes in the stratum 
corneum th ickness per se, because enzyme activity was com -
parable in stratum corneum from human plantar and abdomi -
nal skin stratum corneum, and from other dermatoses charac-
terized by a thickened stratum corneum (ichthyosis vulgaris 
and nonbullous congenital ichthyosis scale). 
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F1 r. 2. The histopathology of control (vehicle- treated) (a ), CS-trea ted (b) , a nd hexadecane-treated (c) skin. Whereas the epidermis and 
dermis appea r s imilar in the cont rol and CS-t rea ted samples, the stratum co rneum is de monstrably thicker in CS-treated control skin. The 
in.~e rt on (b) demonstrates the CS -provoked histology at higher magnification. Note aga in the normal thickness of the viable epidermis and 
absence of mitotic figures. In cont rast, hexadecane, which also produces increased st ratum corneum thickness, demonstrates acanthosis, increased 
dermal cellul a ri ty, and a n increase in mitotic fi gures. a and b, X 225; insets, X 750; c, X 300. 
T AllL E I. H istometric parameters of treated us normal skin 
T opica l age m 
Pa ramete r Cholesterol 
sul fa te D H EA S Hexadecan e Norma l 
!'-it mtum corneum 10.:1 ± 1.1 !1. \ ± 0.7 11.5 ± J.:l :!.6 ± 0.5 
thick ness {mi cro nsr' 
T hick ne.-, of via bl e 20. 1 ± ]. :) 2.1 ± 1.7 4:1. 6 ± 0.8 18.8 ± 1.9 
cp ic!Prmi s tm i(; rons) 
Numh£.: r tJf nucleated 2.2 ± 0.4 vJ ± o.:; 5.5 ± 0.8 2.0 ± 0.4 5 
ce ll lnye rs 
"Signifi ca nt di fference"' cholest e ro l sulfate vs cont ro l, p < 0.00 1: DH EAS vs 
contro l. p < o.o:,. 
TAr\ I.E I I. Comparative labeling t:ndices of cholesterol sulfate- treated us 
control an imals 
T rea tme nt 
Choleste ro l sulfate (n = 3) 
Hexadeca ne (n = ::J) 
Cont rol (n = ~J ) 
Labeling index (mea n ± SEM )" 
8.9 ± 1.3% 
12.4 ± 1.5% 
7.2 ± 0.3% 
--- --- -------------------
fo' or r holest erol sulfate vs control, p > 0.1; for hexadeca ne vs cont rol, 
p < 0.0 1. 
"Percent labeled cells/1000 basal ce lls counted. 
Penetration Characteristics of T opical Cholesterol S ulfate 
To dete rmin e t he fa t e o f topically a pplied CS wi t hin t he 
s kin , we app lied t race a m oun t of ["H] CS to t he backs of ha irless 
mice , a nd sa mpled t he a m ount o f la be l in va ri ous s t ra tum 
corneum a nd v ia ble s kin laye rs a fte r 24 h . As seen in T a ble lV 
about 99% o f recove red la be l is retained wi t hin t he stratum 
co rneu m , wi t h most o f t he coun ts s till in t he oute rmost laye rs, 
with o n ly a bout 1% of applied la be l was recover ed fro m all of 
TABLE IlL Modulation of steroid sulfatase activity by topical 
cholesterol sulfate" 
Week (# sa mples ) 
0 (3) 
1 (3) 
3 (4) 
Enzyme activi ty 
(cpm/ mg protein )' 
17,903 
22,302 
36,562 
" Stratum corneum sheets obtained by treatmen t of whole skin with 
staphylococcal epidermolytic toxin 125 ]. 
1
' Mea n of 3- 4 separate determinat ions. 
the subjacent, viable skin layers. Alt hough it is possible t h at 
some of the label was transport ed via t he circulation to other 
tissues, we we re unable to recove r counts above background 
level fro m liver, kidney, or gastroin testina l tract from the same 
a nima ls. 
Transepidermal Water Loss 
N o ne of the treated sites (CS, DHEAS, cholesterol, or vehi -
cle ) de monstrated increased TEWL in comparison to untrea ted 
contro ls (da ta not s hown). 
DISC USSION 
Role of Topical Lipids in Provocation of Pathologic Scaling 
The results presented in these studies support the view t h a t 
disturba nces in the compos it ion of strat um corneum lipids m ay 
influence desquamation. Since RXLI represents a systemic 
lipidos is in which a single metabolic disturbance, namely al -
tered cholesteroi :CS ratio [21), is linked with pathologic scaling 
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TABLE I V. Penet ration of topically applied ('H) cholesterol sulfate 
across hairless mouse stratum corneum" 
Counts in successive tape-st rippings 
Stripping# 
Exp. I (% ToLa l) Exp . 2 (% Tota l) 
1 190,586 (68.7) 330,601 (6 1.8) 
2 44 ,650 (16.1) 133,870 (25.0) 
3 19,756 (7.1) 43,082 (8.0) 
4 7,363 (2 .7) 18,372 (3.4) 
5 6,202 (2.2) 5,096 (0.9) 
6 4,547 (1.6) 1,262 (0.2) 
7 2,777 (1.0) 1,901 (0.4) 
8 1,262 (0.5) 1,015 (0.2) 
gb (3,835) (3,695) 
Tota l: 277,143 535,199 
• Strippings performed 22- 24 h after application of 10 X J 06 total 
coun ts of [''H] cholesterol sulfate in DMSO (see Materials an.d Meth-
ods ) -
b Sample represents all skin layers that underlie stripped site ( = 
viable epidermis +dermis + portion of subcutaneous fat, see Materials 
and M e thods). 
[22,23,30], we attempted to provoke disease by applying ~S 
directly to t he skin. CS, but not another substrate of stero1d 
sulfatase, DH E AS, provoked abnormal scale. Alt hough the 
degr ee of scaling was judged to be "mild," our impression was 
confirmed both by histology a nd by measurement of stratum 
corne um t hickness in froze n sections . 
Despite t he seemingly specific role of CS in scale induction, 
we fe lt t hat it was important to determine whether t he abnor-
mal scale was a prima ry or secondary phenomenon . Excessive 
scale is associated wi t h lipid abnormali t ies in several other 
clin ical situations [7-9,15-17] and animal models [10,31]. Un-
like oth er models of scaling in mice, e.g. EFA defi ciency [11 ,32] 
and t h e topical hexadecane model [27], where excessive scale 
roay be secondary to ce llula r overproduction rather t han pro-
lo nged retent ion, CS did not produce overproduction as judged 
by: (1) absence of acant hosis or increased mitotic figures (Fig 
2); (2) n orm al labeling index (T able II) ; and (3) normal TEWL 
(TEWL regularly increases in hi gh- turnove r scaling derma-
toses, s u ch as pso rias is [33], EFA defi ciency (34], and nonbul -
lous con geni tal icht hyosiform erythroderma (35 ]) . T hese re-
sults were not unexpected in view of t he normal epidermal cell 
turnove r rates in patients wi t h RXLI (36]. 
T his work suppo rts the hypothesis that the stratum corneum 
reten t io n in RX LI results from a local disturbance caused by 
accu m u lation of excess CS in stratum co rneum intercellula r 
domains. An alternative possibility, i.e ., t hat topically applied 
CS p rovokes scale through an effect on choleste rol metabolism 
in t h e v iable epidermis seems less likely since little labeled CS 
appear s to reach t he viable epidermis. On t he other hand, 
sever a l pha rmacologic inh ibi tors of post-lanosterol cholesterol 
biosyn t hesis also produce abnormal scale in humans (7- 9] and 
in experimental animals [10]. Moreover, CS directly inhibi ts 
de novo synthesis of cholesterol by inhibi t ing the rate- limit ing 
enzyme in cholesterol biosynt hesis, 3-hydroxy-3- methyl glu-
caryl coenzyme A reductase, in both human keratinocytes and 
fibrob lasts in vitro [37 J, and stratum corneum demonstrates 
not o nly increased CS, but a lso signi ficant ly reduced levels of 
free ster ols [21] . 
S ince CS [22,23 ], as other stratum co rneum lipids, is located 
in mem b rane domains in t he stratum corneum [26], it is idea lly 
situated to part icipate in intercellu lar cohesive p !1enomena. 
Following topica l application it is likely, bu t not proved in t hese 
studies, t hat epicutaneously applied CS inspissates into t he 
interce llular lipid mi xture. Once residing in t he stratum cor -
neum interstices, t here a re severa l direct or indirect mecha-
nisms t h at could exp la in increased intercellu la r cohesion lead-
ing to abnorma l desqua mation: (1) highly polar sulfate groups 
on the CS molecule mi ght be extensively cross-linked, e.g., by 
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calciu m [22]; (2) a lter ations in t he choleste rol:CS ratio in t he 
intercellular li pid mixture of the stratum corneum would ab-
rogate t he phase t ransition propert ies of t hese lipids [38] lead-
ing to increased cohesion. Further studies in defin ed model 
systems will be required to clari fy t he molecular mechanism of 
abnorma l cohesion in both RXLI and in t his modeL 
Role of Stratum Corneum Metabolism in the Regulation of 
Cohesion and Desquamation 
T he stratum corneum genera lly is regarded as metabolically 
inert, an assumption based upon both t he absence of cellular 
organelles to provide an energy source, and t he presum ably 
hostile condi t ions (low pH, temperature, a nd humidity), which 
would not favor en zyme activity. Yet, wit h the discovery t hat 
glycosidase act ivity, presumably directed at membrane glyco-
conjugates [39], and steroid sul fatase activity [22,23] are pres-
ent in abundance in the stratum corneum, it appears li kely t hat 
the stratum corneum is metabolically active, perhaps part ici-
pating in t he control of its own cohesion and desquamatio n. 
Since exogenous CS provokes abnormal scale, t hese resul ts 
furt her stress the importa nce of tight regu lation of CS levels 
within the stratum corneum for t he maintenance of normal 
desquamation (40] . H owever, we do not yet have an explanation 
for t he d isappearance of sca le wi th prolonged topical applica-
tions at a constant dose level. T he studies reported he re have 
not demonstrated a conclusive role for enzyme induction in t he 
modulation of desquamation. Another possibili ty might be t hat 
the t hickened stratum corneum impedes furt her access of CS. 
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